15-31049313-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001252024.2(TRPM1):​c.1572+62G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.539 in 1,610,592 control chromosomes in the GnomAD database, including 242,158 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.47 ( 18747 hom., cov: 32)
Exomes 𝑓: 0.55 ( 223411 hom. )

Consequence

TRPM1
NM_001252024.2 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.252

Publications

7 publications found
Variant links:
Genes affected
TRPM1 (HGNC:7146): (transient receptor potential cation channel subfamily M member 1) This gene encodes a member of the transient receptor potential melastatin subfamily of transient receptor potential ion channels. The encoded protein is a calcium permeable cation channel that is expressed in melanocytes and may play a role in melanin synthesis. Specific mutations in this gene are the cause autosomal recessive complete congenital stationary night blindness-1C. The expression of this protein is inversely correlated with melanoma aggressiveness and as such it is used as a prognostic marker for melanoma metastasis. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Oct 2011]
TRPM1 Gene-Disease associations (from GenCC):
  • congenital stationary night blindness 1C
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • TRPM1-related retinopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • congenital stationary night blindness
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 15-31049313-C-T is Benign according to our data. Variant chr15-31049313-C-T is described in CliVar as Benign. Clinvar id is 1261772.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr15-31049313-C-T is described in CliVar as Benign. Clinvar id is 1261772.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr15-31049313-C-T is described in CliVar as Benign. Clinvar id is 1261772.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr15-31049313-C-T is described in CliVar as Benign. Clinvar id is 1261772.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr15-31049313-C-T is described in CliVar as Benign. Clinvar id is 1261772.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr15-31049313-C-T is described in CliVar as Benign. Clinvar id is 1261772.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr15-31049313-C-T is described in CliVar as Benign. Clinvar id is 1261772.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr15-31049313-C-T is described in CliVar as Benign. Clinvar id is 1261772.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr15-31049313-C-T is described in CliVar as Benign. Clinvar id is 1261772.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.918 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TRPM1NM_001252024.2 linkc.1572+62G>A intron_variant Intron 13 of 27 ENST00000256552.11 NP_001238953.1 Q7Z4N2-6
TRPM1NM_001252020.2 linkc.1623+62G>A intron_variant Intron 12 of 26 NP_001238949.1 Q7Z4N2-5
TRPM1NM_002420.6 linkc.1506+62G>A intron_variant Intron 12 of 26 NP_002411.3 Q7Z4N2-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TRPM1ENST00000256552.11 linkc.1572+62G>A intron_variant Intron 13 of 27 1 NM_001252024.2 ENSP00000256552.7 Q7Z4N2-6

Frequencies

GnomAD3 genomes
AF:
0.466
AC:
70884
AN:
151968
Hom.:
18751
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.207
Gnomad AMI
AF:
0.406
Gnomad AMR
AF:
0.565
Gnomad ASJ
AF:
0.554
Gnomad EAS
AF:
0.940
Gnomad SAS
AF:
0.505
Gnomad FIN
AF:
0.539
Gnomad MID
AF:
0.497
Gnomad NFE
AF:
0.547
Gnomad OTH
AF:
0.497
GnomAD4 exome
AF:
0.546
AC:
797028
AN:
1458504
Hom.:
223411
AF XY:
0.545
AC XY:
395415
AN XY:
725712
show subpopulations
African (AFR)
AF:
0.187
AC:
6266
AN:
33426
American (AMR)
AF:
0.589
AC:
26336
AN:
44700
Ashkenazi Jewish (ASJ)
AF:
0.551
AC:
14382
AN:
26102
East Asian (EAS)
AF:
0.909
AC:
36066
AN:
39678
South Asian (SAS)
AF:
0.476
AC:
40967
AN:
86086
European-Finnish (FIN)
AF:
0.536
AC:
28194
AN:
52604
Middle Eastern (MID)
AF:
0.459
AC:
2636
AN:
5740
European-Non Finnish (NFE)
AF:
0.549
AC:
609358
AN:
1109912
Other (OTH)
AF:
0.545
AC:
32823
AN:
60256
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
19330
38661
57991
77322
96652
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
17162
34324
51486
68648
85810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.466
AC:
70901
AN:
152088
Hom.:
18747
Cov.:
32
AF XY:
0.470
AC XY:
34957
AN XY:
74346
show subpopulations
African (AFR)
AF:
0.207
AC:
8579
AN:
41484
American (AMR)
AF:
0.565
AC:
8633
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.554
AC:
1921
AN:
3466
East Asian (EAS)
AF:
0.940
AC:
4867
AN:
5180
South Asian (SAS)
AF:
0.505
AC:
2434
AN:
4820
European-Finnish (FIN)
AF:
0.539
AC:
5696
AN:
10574
Middle Eastern (MID)
AF:
0.500
AC:
147
AN:
294
European-Non Finnish (NFE)
AF:
0.547
AC:
37204
AN:
67962
Other (OTH)
AF:
0.497
AC:
1050
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1737
3473
5210
6946
8683
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
644
1288
1932
2576
3220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.451
Hom.:
2592
Bravo
AF:
0.458
Asia WGS
AF:
0.649
AC:
2252
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.34
DANN
Benign
0.53
PhyloP100
-0.25
Mutation Taster
=20/80
disease causing (long InDel)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2288241; hg19: chr15-31341516; COSMIC: COSV56632205; API